Utah Med (UTMD): Rasio kapitalisasi pasar marang pendapatan

Simbol lan logo merek Utah Medical (UTMD)

A conservative approach to quality control and personnel policy minimizes operational risks for Utah Medical Products (UTMD). The current price-to-sales ratio visualizes this stability, with 6.50 serving as the final level marker. Resilience is driven by high-margin niches in neonatology and gynecology. Long-term clinical dependence on the brand's consumables guarantees a steady cash flow, confirming the strength of the business model.

Rasio rega marang pendapatan: Utah Medical Products, Inc. (UTMD) kanggo 04.07.2022 - 14.11.2026

Rincian metrik lan analitis perusahaan Utah Medical (UTMD)

- kuotasi lan prakiraan analis:
Ringkesan analitik perusahaan:utahmed.com
Produk seri utahmed.com

The P/S ratio determines the market value of a business relative to its actual sales volume, allowing for an assessment of the premium paid per unit of revenue. Analyzing the price-to-sales metric helps identify the fair value of Utah Medical Products (UTMD), where the high margins of specialized medical plastics and patent protection make the model scalable, ensuring operational efficiency with minimal production costs.

Pesaing Utah Medical Products

Kapitalisasi marang volume dodolan ISRG|Rasio rega marang pendapatan Danaher DHR|Rasio kapitalisasi pasar marang pendapatan BDX|STE: Kapitalisasi marang pendapatan|WST - Multiplikator P/S|Baxter International (BAX) - Rasio rega marang pendapatan|Kapitalisasi marang pendapatan masimo.com|STVN (Stevanato Group) - Multiplikator P/S|Rega marang dodolan Teleflex Inc. TFX|Rasio rega marang pendapatan Merit Medical Systems Inc (MMSI)|Nobel Biocare - Rasio kapitalisasi marang pendapatan|ICU Medical, Inc. - Kapitalisasi marang pendapatan|Kapitalisasi marang volume dodolan XRAY (dentsplysirona.com)|LMAT - Rasio rega marang pendapatan|Koefisien rega marang pendapatan AtriCure Inc ATRC|STAA (STAAR Surgical Corp) - Kapitalisasi marang pendapatan|Niagen (NAGE) - Multiplikator P/S|Kapitalisasi marang pendapatan ZIMV|ANGO (angiodynamics.com) - Kapitalisasi marang volume dodolan|Multiplikator P/S CERS|Multiplikator P/S Alpha Teknova (TKNO)|Multiplikator P/S MGRM (Monogram Technologies Inc)|Rasio kapitalisasi pasar marang pendapatan STSS|INFU: Kapitalisasi marang pendapatan|Rasio kapitalisasi pasar marang pendapatan KRMD (KORU Medical Systems)|Nyxoah (NYXH) - Rasio rega marang pendapatan|Kapitalisasi marang pendapatan Microbot Medical, Inc.|PDEX (Pro-Dex Corp) - Multiplikator P/S|Rega marang dodolan Zentek Corp ZTEK|Multiplikator P/S ELUT|milestonescientific.com - Rasio kapitalisasi marang pendapatan|Multiplikator P/S NXGL (NEXGEL)|Koefisien rega marang pendapatan Retractable Technologies Inc. (RVP)|Harvard Bioscience - Multiplikator P/S|Femasys Corporation (FEMY) - Kapitalisasi marang pendapatan|MHUA: Multiplikator P/S|Predictive Oncology Inc. (POAI) - Multiplikator P/S|Rasio rega marang pendapatan Callan JMB Inc.|Rasio rega marang pendapatan ATRI|Kapitalisasi marang pendapatan NURO (NeuroMetrix Corp)